financetom
Business
financetom
/
Business
/
Palo Alto Networks Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Palo Alto Networks Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Aug 15, 2025 6:21 AM

Palo Alto Networks, Inc ( PANW ). will release financial results for the fourth quarter after the closing bell on Monday, Aug. 18.

Analysts expect the Santa Clara, California-based company to report quarterly earnings at 89 cents per share, up from 75 cents per share in the year-ago period. Palo Alto Networks ( PANW ) projects to report quarterly revenue at $2.5 billion, compared to $2.19 billion a year earlier, according to data from Benzinga Pro.

On July 30, Palo Alto entered into a definitive agreement with CyberArk to acquire the identity security company. Shareholders of CyberArk will receive $45 in cash and 2.2005 shares of Palo Alto common stock for each CyberArk share held for an approximate equity value of $25 billion.

Palo Alto Networks ( PANW ) shares fell 1.9% to close at $173.55 on Thursday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

Rosenblatt analyst Catherine Trebnick maintained a Buy rating and cut the price target from $235 to $215 on Aug. 14, 2025. This analyst has an accuracy rate of 63%.

Deutsche Bank analyst Brad Zelnick upgraded the stock from Hold to Buy and boosted the price target from $200 to $220 on Aug. 13, 2025. This analyst has an accuracy rate of 68%.

UBS analyst Roger Boyd maintained a Neutral rating and cut the price target from $200 to $185 on Aug. 12, 2025. This analyst has an accuracy rate of 62%.

Piper Sandler analyst Rob Owens upgraded the stock from Neutral to Overweight and increased the price target from $200 to $225 on Aug. 12, 2025. This analyst has an accuracy rate of 79%.

DA Davidson analyst Rudy Kessinger maintained a Buy rating and cut the price target from $225 to $215 on July 31, 2025. This analyst has an accuracy rate of 60%.

Considering buying PANW stock? Here’s what analysts think:

Read This Next:

Wall Street’s Most Accurate Analysts Give Their Take On 3 Defensive Stocks Delivering High-Dividend Yields

Photo via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
DiamondRock Hospitality to Transfer Listing to Nasdaq From NYSE
DiamondRock Hospitality to Transfer Listing to Nasdaq From NYSE
Nov 13, 2025
08:14 AM EST, 11/13/2025 (MT Newswires) -- DiamondRock Hospitality ( DRH ) said Thursday it will voluntarily transfer its class A common shares listing to Nasdaq from the New York Stock Exchange. The company said it anticipates its common shares to start trading on the Nasdaq Global Select Market on Dec. 1, under the current DRH ticker. ...
BioNTech says collaboration with Pfizer remains unchanged
BioNTech says collaboration with Pfizer remains unchanged
Nov 13, 2025
FRANKFURT, Nov 13 (Reuters) - BioNTech said on Thursday that its collaboration with Pfizer ( PFE ) has not changed, when asked to comment on a report that Pfizer ( PFE ) is looking to sell its stake in the German biotech firm. We continue to have a close and strong collaboration, a spokesperson said in a statement, adding that...
Genetic medicines firm MeiraGTx misses Q3 revenue expectations, net loss widens
Genetic medicines firm MeiraGTx misses Q3 revenue expectations, net loss widens
Nov 13, 2025
Overview * MeiraGTx ( MGTX ) Q3 revenue misses analyst expectations, declining significantly from last year * Company enters strategic collaboration with Eli Lilly, including $75 mln upfront payment * Net loss widens to $50.5 mln in Q3, driven by increased R&D expenses Outlook * Company anticipates Phase 2 data for AAV-hAQP1 in early 2027 * MeiraGTx ( MGTX )...
Nortech Systems Q3 net loss narrows due to restructuring efforts 
Nortech Systems Q3 net loss narrows due to restructuring efforts 
Nov 13, 2025
Overview * Nortech Q3 2025 net sales decline 2.9% yr/yr to $30.5 mln * Net loss narrows to $146,000 in Q3 2025 from $739,000 in Q3 2024 * Adjusted EBITDA rises to $1.3 mln in Q3 2025 from $0.1 mln in Q3 2024 Outlook * Company highlights AS9100:D certification at Monterrey facility enhancing aerospace offerings * Nortech ( NSYS )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved